Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) reported earnings for its first quarter that Increased, from last year
The company's bottom line totaled RMB444.33 million, or RMB0.27 per share. This compares with RMB375.01 million, or RMB0.21 per share, last year.
The company's revenue for the period fell 1.4% to RMB2.335 billion from RMB2.368 billion last year.
Zhejiang Huahai Pharmaceutical Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB444.33 Mln. vs. RMB375.01 Mln. last year.-EPS: RMB0.27 vs. RMB0.21 last year.-Revenue: RMB2.335 Bln vs. RMB2.368 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.